Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,490,840
-$3,631,260 QoQ
Shares Held
61,912
-66.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,095
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $166,003,072 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
282,635 | $36,318,597 | |
| 2 | JNJ |
Johnson & Johnson
|
113,733 | $28,884,770 | |
| 3 | LLY |
ELI LILLY & Co
|
21,997 | $26,383,863 | |
| 4 | AMGN |
Amgen Inc
|
63,607 | $23,033,366 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
369,878 | $21,312,370 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
138,734 | $17,527,653 | |
| 7 | ABBV |
AbbVie Inc.
|
42,182 | $10,614,678 | |
| 8 | PFE |
Pfizer Inc
This page
|
61,912 | $1,490,840 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,490,840 | 61,912 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,122,100 | 182,411 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,542,033 | 182,411 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,661,158 | 182,934 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,447,482 | 183,477 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,523,848 | 178,526 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,435,391 | 167,184 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,870,081 | 168,282 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,858,727 | 173,650 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,478,320 | 233,453 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,680,435 | 336,243 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,548,533 | 348,162 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,001,299 | 354,452 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,179,632 | 347,540 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,634,760 | 149,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,628,283 | 151,469 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,010,307 | 152,781 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,108,290 | 117,989 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,755,154 | 46,658 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,972,137 | 45,853 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,807,155 | 46,148 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,636,704 | 210,784 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,960,314 | 107,588 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,954,934 | 107,764 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,540,236 | 108,264 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,903,781 | 88,964 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||